User profiles for "author:Sandra Eloranta"
Sandra ElorantaClinical Epidemiology Unit, Department of Medicine, Karolinska Institutet Verified email at ki.se Cited by 4684 |
[HTML][HTML] Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008
M Björkholm, L Ohm, S Eloranta, Å Derolf… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Purpose Chronic myeloid leukemia (CML) management changed dramatically with the
development of imatinib mesylate (IM), the first tyrosine kinase inhibitor targeting the BCR …
development of imatinib mesylate (IM), the first tyrosine kinase inhibitor targeting the BCR …
[HTML][HTML] Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study
M Hultcrantz, SY Kristinsson… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
Purpose Reported survival in patients with myeloproliferative neoplasms (MPNs) shows
great variation. Patients with primary myelofibrosis (PMF) have substantially reduced life …
great variation. Patients with primary myelofibrosis (PMF) have substantially reduced life …
15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL 2): prolonged remissions without survival plateau
CW Eskelund, A Kolstad, M Jerkeman… - British journal of …, 2016 - Wiley Online Library
In recent decades, the prognosis of Mantle Cell Lymphoma (MCL) has been significantly
improved by intensified first‐line regimens containing cytarabine, rituximab and …
improved by intensified first‐line regimens containing cytarabine, rituximab and …
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study
A Leval, E Herweijer, A Ploner… - Journal of the …, 2013 - academic.oup.com
Background Incidence of condyloma, or genital warts (GW), is the earliest possible disease
outcome to measure when assessing the effectiveness of human papillomavirus (HPV) …
outcome to measure when assessing the effectiveness of human papillomavirus (HPV) …
Cancer incidence, survival and mortality: explaining the concepts
L Ellis, LM Woods, J Estève, S Eloranta… - … journal of cancer, 2014 - Wiley Online Library
Cancer incidence, survival and mortality are essential population‐based indicators for public
health and cancer control. Confusion and misunderstanding still surround the estimation …
health and cancer control. Confusion and misunderstanding still surround the estimation …
The prevalence of mental health problems in elite athletes
Objectives The first aim was to examine mental health problems (MHP) in elite athletes
addressing prevalence, sex-differences, onset, recurrent episodes, help-seeking, symptoms …
addressing prevalence, sex-differences, onset, recurrent episodes, help-seeking, symptoms …
Predictive models for clinical decision making: Deep dives in practical machine learning
S Eloranta, M Boman - Journal of Internal Medicine, 2022 - Wiley Online Library
The deployment of machine learning for tasks relevant to complementing standard of care
and advancing tools for precision health has gained much attention in the clinical …
and advancing tools for precision health has gained much attention in the clinical …
[HTML][HTML] Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models
Background When the mortality among a cancer patient group returns to the same level as
in the general population, that is, the patients no longer experience excess mortality, the …
in the general population, that is, the patients no longer experience excess mortality, the …
Risk and cause of death in patients diagnosed with myeloproliferative neoplasms in Sweden between 1973 and 2005: a population-based study
M Hultcrantz, SR Wilkes, SY Kristinsson… - Journal of Clinical …, 2015 - ascopubs.org
Purpose Myeloproliferative neoplasms (MPNs) are associated with a shortened life
expectancy. We assessed causes of death in patients with MPN and matched controls using …
expectancy. We assessed causes of death in patients with MPN and matched controls using …
Duration of red blood cell storage and survival of transfused patients (CME)
G Edgren, M Kamper‐Jørgensen, S Eloranta… - …, 2010 - Wiley Online Library
BACKGROUND: Disquieting reports of increased complication and death rates after
transfusions of red blood cells (RBCs) stored for more than 14 days prompted us to perform …
transfusions of red blood cells (RBCs) stored for more than 14 days prompted us to perform …